Stay updated on BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This is a metadata/version change with no changes to study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-03-11T23:31:33.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated to v3.4.2; the older government-funding notice (v3.4.1) and its operating-status messaging were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T11:16:11.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and guidance to status updates. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T06:30:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now includes a glossary toggle and updated QC metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0). The previous version displayed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-28T04:28:24.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page now displays a new revision line 'Revision: v3.3.4' and removes the previous 'Revision: v3.3.3'; no other content appears to be affected.
    Difference
    0.0%
    Check dated 2026-01-14T01:35:37.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Expanded the Study Locations section to include numerous US states and international sites (e.g., Fukuoka, Kanagawa, Nara, Tokyo) and updated the revision to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T10:17:37.000Z thumbnail image

Stay in the know with updates to BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BMS-986036 in NASH Stage 3 Fibrosis Clinical Trial page.